Nasdaq · Healthcare
Privia Health Group, Inc. (PRVA)
As-reported financials and recent SEC filings for Privia Health Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.12B
Net income
$22.9M
Net margin
1.1%
Diluted EPS
$0.18
ROE
2.9%
P/E (TTM)
150.4×
Market cap
$3.22B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.2M |
| Gross profit | — | — | — | — | — |
| Operating income | $34.2M | $17.0M | $20.6M | $-19.1M | $-217.4M |
| Net income | $22.9M | $14.4M | $23.1M | $-8.6M | $-188.2M |
| Diluted EPS | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-26
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →42026-05-22
View on EDGAR →Go deeper on PRVA
Search Privia Health Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.